Much more than a financial investment
Oncelia is opening a new era in breast cancer screening — a MedTech venture with strong societal, economic and environmental impact.
Why invest in Oncelia
Proven need
A proven, unmet global need
2.3 million new cases in 2022 · projected to reach 3.2 million by 2050 · 90 to 95% of cases occur in women with no identifiable risk factor. (IARC / WHO 2025)
Significant market
A massive addressable market
TAM 2.4 billion women · SAM 600M · SOM 120M.
Annual growth (CAGR)
Structural growth driven by demand
Aging population · rising incidence among younger women · the growth of Femtech · mounting pressure on healthcare systems.
Strong societal impact
Reducing mortality through early detection
88% five-year survival with early detection (vs. < 30% at an advanced stage) · 23,000 deaths prevented in France over 14 years thanks to screening.
Feasibility study
A published clinical proof of concept
84.6% sensitivity · 76.9% specificity · 40 patients · Hospices Civils de Lyon · Prof. Marion Cortet · Belmont et al. paper
Team, advisory & partnerships
A multidisciplinary team backed by experts
Industrial synergies
An industrial ecosystem ready to go
Smart sensors & medical textiles · generative and predictive AI · connectivity with healthcare professionals · spin-off of an established industrial group.
Recession-resistant
Health knows no recession
Cancer prevention is a global public health priority, independent of economic cycles. A certified medical device withstands consumer spending cycles.
Multiple exit scenarios
Clearly identified exit routes
Several possible exit scenarios with industrial and strategic players in the MedTech and Femtech sectors.
Social, societal and environmental
Public health
- More frequent screening
- Earlier detection
- Lower mortality
- Better adherence to prevention
Social & equity
- Women take back control of their health
- Fewer inequalities in access (geography, age, demographics)
- Less anxiety between two exams
- Reconnecting women with local primary care
Economic
- Less costly treatment when detected early
- Better targeting of truly at-risk patients
Environmental
- At-home prevention → fewer hospital trips
- Reusable device → less medical waste
- Eco-design built in from the R&D stage
- Very low energy consumption
Join the team
Share our vision? Join a team building the prevention of tomorrow, backed by the strength of an established industrial group.
No open positions at the moment.
Let's talk about the project
Investor or partner? Contact us to receive our investor materials.
Contact us